Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.

Brugière O, Roux A, Le Pavec J, Sroussi D, Parquin F, Pradère P, Dupin C, Bunel V, Mourin G, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Mal H, Suberbielle C, Gautreau C, Caillat-Zucman S, Cazes A, Thabut G, Taupin JL.

Eur Respir J. 2018 Jul 5. pii: 1701898. doi: 10.1183/13993003.01898-2017. [Epub ahead of print]

PMID:
29976654
2.

Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.

Culina S, Lalanne AI, Afonso G, Cerosaletti K, Pinto S, Sebastiani G, Kuranda K, Nigi L, Eugster A, Østerbye T, Maugein A, McLaren JE, Ladell K, Larger E, Beressi JP, Lissina A, Appay V, Davidson HW, Buus S, Price DA, Kuhn M, Bonifacio E, Battaglia M, Caillat-Zucman S, Dotta F, Scharfmann R, Kyewski B, Mallone R; ImMaDiab Study Group, Carel JC, Tubiana-Rufi N, Martinerie L, Poidvin A, JacqzAigrain E, Corvez L, Berruer V, Gautier JF, Baz B, Haddadi N, Andreelli F, Amouyal C, Jaqueminet S, Bourron O, Dasque E, Hartemann A, Lemoine-Yazigi A, Dubois-Laforgue D, Travert F, Feron M, Rolland P, Vignali V, Marre M, Chanson P, Briet C, Guillausseau PJ, Ait-Bachir L, Collet C, Beziaud F, Desforges-Bullet V, Petit-Aubert G, Christin-Maitre S, Fève B, Vatier C, Bourcigaux N, Lautridou C, Lahlou N, Bakouboula P, Elie C, Morel H, Treluyer JM, Gagnerault MC, Maillard C, Jones A.

Sci Immunol. 2018 Feb 2;3(20). pii: eaao4013. doi: 10.1126/sciimmunol.aao4013.

PMID:
29429978
3.

Ontogeny of human mucosal-associated invariant T cells and related T cell subsets.

Ben Youssef G, Tourret M, Salou M, Ghazarian L, Houdouin V, Mondot S, Mburu Y, Lambert M, Azarnoush S, Diana JS, Virlouvet AL, Peuchmaur M, Schmitz T, Dalle JH, Lantz O, Biran V, Caillat-Zucman S.

J Exp Med. 2018 Feb 5;215(2):459-479. doi: 10.1084/jem.20171739. Epub 2018 Jan 16.

PMID:
29339446
4.

Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child.

Ghazarian L, Caillat-Zucman S, Houdouin V.

Front Immunol. 2017 Dec 15;8:1837. doi: 10.3389/fimmu.2017.01837. eCollection 2017. Review.

5.

Control of NK Cell Activation by Immune Checkpoint Molecules.

Beldi-Ferchiou A, Caillat-Zucman S.

Int J Mol Sci. 2017 Oct 12;18(10). pii: E2129. doi: 10.3390/ijms18102129. Review.

6.

Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome.

Zuber J, Shonts B, Lau SP, Obradovic A, Fu J, Yang S, Lambert M, Coley S, Weiner J, Thome J, DeWolf S, Farber DL, Shen Y, Caillat-Zucman S, Bhagat G, Griesemer A, Martinez M, Kato T, Sykes M.

Sci Immunol. 2016 Oct;1(4). pii: eaah3732. doi: 10.1126/sciimmunol.aah3732. Epub 2016 Oct 7.

7.

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.

Rusakiewicz S, Perier A, Semeraro M, Pitt JM, Pogge von Strandmann E, Reiners KS, Aspeslagh S, Pipéroglou C, Vély F, Ivagnes A, Jegou S, Halama N, Chaigneau L, Validire P, Christidis C, Perniceni T, Landi B, Berger A, Isambert N, Domont J, Bonvalot S, Terrier P, Adam J, Coindre JM, Emile JF, Poirier-Colame V, Chaba K, Rocha B, Caignard A, Toubert A, Enot D, Koch J, Marabelle A, Lambert M, Caillat-Zucman S, Leyvraz S, Auclair C, Vivier E, Eggermont A, Borg C, Blay JY, Le Cesne A, Mir O, Zitvogel L.

Oncoimmunology. 2016 Apr 25;6(1):e1137418. doi: 10.1080/2162402X.2015.1137418. eCollection 2017.

8.

New insights into the understanding of MHC associations with immune-mediated disorders.

Caillat-Zucman S.

HLA. 2017 Jan;89(1):3-13. doi: 10.1111/tan.12947. Review.

PMID:
28025877
9.

PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.

Beldi-Ferchiou A, Lambert M, Dogniaux S, Vély F, Vivier E, Olive D, Dupuy S, Levasseur F, Zucman D, Lebbé C, Sène D, Hivroz C, Caillat-Zucman S.

Oncotarget. 2016 Nov 8;7(45):72961-72977. doi: 10.18632/oncotarget.12150.

10.

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation.

Morin-Zorman S, Loiseau P, Taupin JL, Caillat-Zucman S.

Front Immunol. 2016 Aug 12;7:307. doi: 10.3389/fimmu.2016.00307. eCollection 2016. Review.

11.

HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.

Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A; ANRS EPF-CO10 Pediatric Cohort and the ANRS EP47 VISCONTI study group.

Lancet HIV. 2016 Jan;3(1):e49-54. doi: 10.1016/S2352-3018(15)00232-5. Epub 2015 Dec 9.

12.

Use of Single-Antigen Flow Beads Assays to Assess Anti-HLA Donor-Specific Antibody Strength.

Loiseau P, Amokhrane K, Visentin J, Kheav VD, Caillat-Zucman S, Taupin JL.

Biol Blood Marrow Transplant. 2016 Feb;22(2):394-395. doi: 10.1016/j.bbmt.2015.11.006. Epub 2015 Nov 17. No abstract available.

13.

Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Gagne K, Loiseau P, Dubois V, Dufossé F, Perrier P, Dormoy A, Jollet I, Renac V, Masson D, Picard C, Lafarge X, Hanau D, Quainon F, Delbos F, Coeffic B, Absi L, Eliaou JF, Moalic V, Fort M, de Matteis M, Theodorou I, Hau F, Batho A, Pedron B, Caillat-Zucman S, Marry E, Raus N, Yakoub-Agha I, Cesbron A.

Bone Marrow Transplant. 2015 Feb;50(2):232-6. doi: 10.1038/bmt.2014.253. Epub 2014 Nov 3.

PMID:
25365066
14.

Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases.

Haumonte JB, Caillat-Zucman S, Bretelle F, Lambert M, Lyonnet L, Levy-Mozziconacci A, Farnarier C, Aubert A, Boubli L, Camoin-Jau L, Dignat George F, Paul P.

Biomed Res Int. 2014;2014:653161. doi: 10.1155/2014/653161. Epub 2014 Aug 27.

15.

Evidence after imputation for a role of MICA variants in nonprogression and elite control of HIV type 1 infection.

Le Clerc S, Delaneau O, Coulonges C, Spadoni JL, Labib T, Laville V, Ulveling D, Noirel J, Montes M, Schächter F, Caillat-Zucman S, Zagury JF.

J Infect Dis. 2014 Dec 15;210(12):1946-50. doi: 10.1093/infdis/jiu342. Epub 2014 Jun 16.

PMID:
24939907
16.

Association of PTPN22+1858C/T polymorphism with Type 1 diabetes in the North Indian population.

Kumar N, Kaur G, Kanga U, Tandon N, Caillat-Zucman S, Mehra NK.

Int J Immunogenet. 2014 Aug;41(4):318-23. doi: 10.1111/iji.12129. Epub 2014 Jun 10.

PMID:
24913133
17.

Tissue-specific microvascular endothelial cells show distinct capacity to activate NK cells: implications for the pathophysiology of granulomatosis with polyangiitis.

Tognarelli S, Gayet J, Lambert M, Dupuy S, Karras A, Cohen P, Guillevin L, de Menthon M, Caillat-Zucman S.

J Immunol. 2014 Apr 1;192(7):3399-408. doi: 10.4049/jimmunol.1301508. Epub 2014 Mar 5.

18.

Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering.

Romero AI, Chaput N, Poirier-Colame V, Rusakiewicz S, Jacquelot N, Chaba K, Mortier E, Jacques Y, Caillat-Zucman S, Flament C, Caignard A, Messaoudene M, Aupérin A, Vielh P, Dessen P, Porta C, Mateus C, Ayyoub M, Valmori D, Eggermont A, Robert C, Zitvogel L.

Cancer Res. 2014 Jan 1;74(1):68-80. doi: 10.1158/0008-5472.CAN-13-1186. Epub 2013 Nov 6.

19.

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.

Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, Forsblad-d'Elia H, Omdal R, Wahren-Herlenius M, Jonsson R, Rönnblom L, Nititham J, Taylor KE, Lessard CJ, Sivils KL, Gottenberg JE, Criswell LA, Miceli-Richard C, Zitvogel L, Mariette X.

Sci Transl Med. 2013 Jul 24;5(195):195ra96. doi: 10.1126/scitranslmed.3005727.

20.

Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.

Wilmot-Roussel H, Lévy DJ, Carette C, Caillat-Zucman S, Boitard C, Timsit J, Dubois-Laforgue D.

Diabetes Metab. 2013 May;39(3):244-9. doi: 10.1016/j.diabet.2013.01.002. Epub 2013 Mar 19.

PMID:
23522731
21.

NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers.

Lecuroux C, Saez-Cirion A, Noel N, Ben-Lamine L, Girault I, Caillat-Zucman S, Scott-Algara D, Venet A, Lambotte O.

J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):17-20. doi: 10.1097/QAI.0b013e318274579f.

22.

Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome.

Boita M, Rolla G, Mallone R, Martinuzzi E, Heffler E, Circosta P, Elia AR, Cignetti A, Caillat-Zucman S, de Menthon M, Guida G.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S57-61. Epub 2012 May 14.

PMID:
22640649
23.

Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival.

Rubio MT, Moreira-Teixeira L, Bachy E, Bouillié M, Milpied P, Coman T, Suarez F, Marcais A, Sibon D, Buzyn A, Caillat-Zucman S, Cavazzana-Calvo M, Varet B, Dy M, Hermine O, Leite-de-Moraes M.

Blood. 2012 Sep 6;120(10):2144-54. doi: 10.1182/blood-2012-01-404673. Epub 2012 Jun 22.

24.

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.

Dupuy S, Lambert M, Zucman D, Choukem SP, Tognarelli S, Pages C, Lebbé C, Caillat-Zucman S.

PLoS Pathog. 2012 Jan;8(1):e1002486. doi: 10.1371/journal.ppat.1002486. Epub 2012 Jan 12.

25.

Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's).

de Menthon M, Lambert M, Guiard E, Tognarelli S, Bienvenu B, Karras A, Guillevin L, Caillat-Zucman S.

Arthritis Rheum. 2011 Jul;63(7):2116-26. doi: 10.1002/art.30355.

26.

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Sène D, Levasseur F, Abel M, Lambert M, Camous X, Hernandez C, Pène V, Rosenberg AR, Jouvin-Marche E, Marche PN, Cacoub P, Caillat-Zucman S.

PLoS Pathog. 2010 Nov 11;6(11):e1001184. doi: 10.1371/journal.ppat.1001184.

27.

21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease.

Rottembourg D, Deal C, Lambert M, Mallone R, Carel JC, Lacroix A, Caillat-Zucman S, le Deist F.

J Autoimmun. 2010 Dec;35(4):309-15. doi: 10.1016/j.jaut.2010.07.001. Epub 2010 Aug 3.

PMID:
20685079
28.

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.

Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N.

PLoS One. 2009;4(3):e4942. doi: 10.1371/journal.pone.0004942. Epub 2009 Mar 25.

29.

Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.

Eagle RA, Flack G, Warford A, Martínez-Borra J, Jafferji I, Traherne JA, Ohashi M, Boyle LH, Barrow AD, Caillat-Zucman S, Young NT, Trowsdale J.

PLoS One. 2009;4(2):e4503. doi: 10.1371/journal.pone.0004503. Epub 2009 Feb 18. Erratum in: PLoS ONE. 2009;4(3). doi: 10.1371/annotation/8501cd33-6c9e-437c-9ea1-f96fbb4140d6. PLoS ONE. 2009;4(3). doi: 10.1371/annotation/34238ee8-5128-4f1d-9ae2-6906c9764e49.

30.

Molecular mechanisms of HLA association with autoimmune diseases.

Caillat-Zucman S.

Tissue Antigens. 2009 Jan;73(1):1-8. doi: 10.1111/j.1399-0039.2008.01167.x. Epub 2008 Nov 10. Review.

PMID:
19017300
31.

Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes.

Toma A, Laïka T, Haddouk S, Luce S, Briand JP, Camoin L, Connan F, Lambert M, Caillat-Zucman S, Carel JC, Muller S, Choppin J, Lemonnier F, Boitard C.

Diabetes. 2009 Feb;58(2):394-402. doi: 10.2337/db08-0599. Epub 2008 Nov 14.

32.

Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?

Ménard C, Ghiringhelli F, Roux S, Chaput N, Mateus C, Grohmann U, Caillat-Zucman S, Zitvogel L, Robert C.

Clin Cancer Res. 2008 Aug 15;14(16):5242-9. doi: 10.1158/1078-0432.CCR-07-4797.

33.

Delineation of late onset hypoventilation associated with hypothalamic dysfunction syndrome.

De Pontual L, Trochet D, Caillat-Zucman S, Abou Shenab OA, Bougneres P, Crow Y, Cunningham S, Esteva B, Heberle LC, Leger J, Pinto G, Polak M, Shafik MH, Straus C, Trang H, Munnich A, Lyonnet S, Desguerre I, Amiel J.

Pediatr Res. 2008 Dec;64(6):689-94. doi: 10.1203/PDR.0b013e318187dd0e.

PMID:
18670370
34.

Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?

Zhang S, Hüe S, Sène D, Penfornis A, Bresson-Hadni S, Kantelip B, Caillat-Zucman S, Vuitton DA.

J Infect Dis. 2008 May 1;197(9):1341-9. doi: 10.1086/586709.

PMID:
18422447
35.

Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data.

Abad S, Monnet D, Caillat-Zucman S, Mrejen S, Blanche P, Chalumeau M, Mouthon L, Dhote R, Brézin AP.

Ocul Immunol Inflamm. 2008 Jan-Feb;16(1):3-8. doi: 10.1080/09273940801923895.

PMID:
18379934
36.

Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease.

Gannagé M, Buzyn A, Bogiatzi SI, Lambert M, Soumelis V, Dal Cortivo L, Cavazzana-Calvo M, Brousse N, Caillat-Zucman S.

Transplantation. 2008 Mar 27;85(6):911-5. doi: 10.1097/TP.0b013e31816691ef.

PMID:
18360276
37.

Adult celiac disease with severe or partial villous atrophy: a comparative study.

Malamut G, Matysiak-Budnik T, Grosdider E, Jais JP, Morales E, Damotte D, Caillat-Zucman S, Brousse N, Cerf-Bensussan N, Jian R, Cellier C.

Gastroenterol Clin Biol. 2008 Mar;32(3):236-42. doi: 10.1016/j.gcb.2008.02.011. Epub 2008 Mar 24.

38.

FCRL3 -169CT functional polymorphism in type 1 diabetes and autoimmunity traits.

Duchatelet S, Caillat-Zucman S, Dubois-Laforgue D, Blanc H, Timsit J, Julier C.

Biomed Pharmacother. 2008 Mar;62(3):153-7. Epub 2007 Oct 8.

PMID:
17961971
39.

Antigen crosspresentation by human plasmacytoid dendritic cells.

Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P, Heshmati F, Guillet JG, Gannagé M, Caillat-Zucman S, Casartelli N, Schwartz O, De la Salle H, Hanau D, Hosmalin A, Marañón C.

Immunity. 2007 Sep;27(3):481-92.

40.

Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.

Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J, Erlich HA, Cucca F, Pugliese A, Steenkiste A, Dorman JS, Caillat-Zucman S, Hermann R, Ilonen J, Lambert AP, Bingley PJ, Gillespie KM, Lernmark A, Sanjeevi CB, Rønningen KS, Undlien DE, Thorsby E, Petrone A, Buzzetti R, Koeleman BP, Roep BO, Saruhan-Direskeneli G, Uyar FA, Günoz H, Gorodezky C, Alaez C, Boehm BO, Mlynarski W, Ikegami H, Berrino M, Fasano ME, Dametto E, Israel S, Brautbar C, Santiago-Cortes A, Frazer de Llado T, She JX, Bugawan TL, Rotter JI, Raffel L, Zeidler A, Leyva-Cobian F, Hawkins BR, Chan SH, Castano L, Pociot F, Nerup J.

Tissue Antigens. 2007 Aug;70(2):110-27.

PMID:
17610416
41.

Soluble MHC Class I chain-related molecule serum levels are predictive markers of implantation failure and successful term pregnancies following IVF.

Porcu-Buisson G, Lambert M, Lyonnet L, Loundou A, Gamerre M, Camoin-Jau L, Dignat-George F, Caillat-Zucman S, Paul P.

Hum Reprod. 2007 Aug;22(8):2261-6. Epub 2007 Jun 23.

PMID:
17586836
42.

CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.

Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A.

Gastroenterology. 2007 Jun;132(7):2346-58. Epub 2007 Mar 16.

PMID:
17570210
43.

Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population.

Zucman D, Truchis Pd, Majerholc C, Stegman S, Caillat-Zucman S.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):1-3.

PMID:
17356469
44.

Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.

Matysiak-Budnik T, Malamut G, de Serre NP, Grosdidier E, Seguier S, Brousse N, Caillat-Zucman S, Cerf-Bensussan N, Schmitz J, Cellier C.

Gut. 2007 Oct;56(10):1379-86. Epub 2007 Feb 15.

45.

Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype.

Cavazzana-Calvo M, Carlier F, Le Deist F, Morillon E, Taupin P, Gautier D, Radford-Weiss I, Caillat-Zucman S, Neven B, Blanche S, Cheynier R, Fischer A, Hacein-Bey-Abina S.

Blood. 2007 May 15;109(10):4575-81. Epub 2007 Feb 1.

46.

PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits.

Chelala C, Duchatelet S, Joffret ML, Bergholdt R, Dubois-Laforgue D, Ghandil P, Pociot F, Caillat-Zucman S, Timsit J, Julier C.

Diabetes. 2007 Feb;56(2):522-6.

47.

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.

Abel M, Sène D, Pol S, Bourlière M, Poynard T, Charlotte F, Cacoub P, Caillat-Zucman S.

Hepatology. 2006 Dec;44(6):1607-16.

PMID:
17133491
48.

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.

Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F.

J Hepatol. 2006 Dec;45(6):844-50. Epub 2006 Sep 28.

PMID:
17050030
49.

Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma.

Lambert M, Gannagé M, Karras A, Abel M, Legendre C, Kerob D, Agbalika F, Girard PM, Lebbe C, Caillat-Zucman S.

Blood. 2006 Dec 1;108(12):3871-80. Epub 2006 Aug 22.

50.

Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism.

Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S.

Hum Immunol. 2006 Aug;67(8):612-7. Epub 2006 May 24.

PMID:
16916657

Supplemental Content

Loading ...
Support Center